CIP2A and lung carcinoma: An increased expression of CIP2A had been detected in multiple malignancies, such as gastric cancer[11, 12], breast cancer[13, 14], prostate cancer[15, 16], lung cancer[17], papillary thyroid carcinoma[18] and head and neck squamous cell carcinomas [19].